#Evogene

@newsen.bsky.social

5 days ago

Evogene Set to Showcase Key Pharma Innovations at BIO-Europe Spring 2026 At BIO-Europe Spring 2026, Evogene Ltd. aims to highlight its groundbreaking advancements in pharmaceutical discovery driven by AI. This event is pivotal in displaying their innovative technologies.

Evogene Set to Showcase Key Pharma Innovations at BIO-Europe Spring 2026 #Portugal #Lisbon #Evogene #ChemPass_AI #Pharma_Discovery

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 week ago

Evogene Reports Significant Financial Adjustments for Fourth Quarter and Full Year 2025 Evogene Ltd. announces financial results for Q4 and full year 2025, highlighting a strategic focus on its ChemPass AI™ platform for drug discovery.

Evogene Reports Significant Financial Adjustments for Fourth Quarter and Full Year 2025 #Israel #financial_results #Rehovot #Evogene #ChemPass_AI

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Evogene's Transformative Strategy to Create Long-Term Value for Shareholders Discover Evogene's significant advancements and strategic transformation, focusing on long-term value creation in pharmaceuticals and agriculture.

Evogene's Transformative Strategy to Create Long-Term Value for Shareholders #Israel #Rehovot #Evogene #ChemPass_AI #Ofer_Haviv

0 0 0 0

@d-and-d-world.bsky.social

3 weeks ago

Evogene and Australian Uni partner to tackle chemotherapy resistance in lung cancer AI-driven collaboration between the Israeli company and Queensland University of Technology targets cellular pathways to overcome treatment hurdles in non-small cell lung cancer.

Evogene and QUT team up to fight chemotherapy resistance in lung cancer using AI. The collaboration targets cellular pathways to develop new therapies for patients with limited options.
#News #Evogene #QUT #AI #CancerResearch #LungCancer #Biotech #DrugDiscovery

1 0 0 0

Phalguni Deswal

@phalguniddw.bsky.social

3 weeks ago

Evogene and Australian Uni partner to tackle chemotherapy resistance in lung cancer AI-driven collaboration between the Israeli company and Queensland University of Technology targets cellular pathways to overcome treatment hurdles in non-small cell lung cancer.

Evogene and QUT team up to fight chemotherapy resistance in lung cancer using AI. The collaboration targets cellular pathways to develop new therapies for patients with limited options.
#News #Evogene #QUT #AI #CancerResearch #LungCancer #Biotech #DrugDiscovery

1 0 0 0

pharmaphorum

@pharmaphorum.bsky.social

3 weeks ago

Recent developments in the #biopharma #AI world include an #alliance between #ThermoFisherScientific and #Datavant, plus news from #Insilico, #Evinova, #BPGbio, #Evogene, and #AMPLY.

buff.ly/2z49luQ

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 month ago

Innovative Partnership to Develop New Therapies for Neutrophil-Driven Inflammatory Conditions A groundbreaking collaboration involves Evogene, Systasy, and LMU University Hospital Munich to create new therapies targeting neutrophil-related inflammatory diseases.

Innovative Partnership to Develop New Therapies for Neutrophil-Driven Inflammatory Conditions #Germany #Munich #Evogene #Systasy #LMU_Hospital

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 month ago

Evogene Secures $3.4 Million from Warrant Inducement Deal to Boost Growth Evogene Ltd. has announced a warrant inducement agreement generating $3.4 million in gross proceeds to support its innovative efforts in chemistry.

Evogene Secures $3.4 Million from Warrant Inducement Deal to Boost Growth #Israel #Rehovot #Warrant_Inducement #Evogene #ChemPass_AI

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 month ago

Evogene and Google Cloud Collaborate to Enhance AI in ChemPass AI™ for Drug Development Evogene extends its partnership with Google Cloud, integrating AI agents into ChemPass AI™ to enhance small-molecule discovery, promising quicker pharmaceutical development.

Evogene and Google Cloud Collaborate to Enhance AI in ChemPass AI™ for Drug Development #Israel #Google_Cloud #Rehovot #Evogene #ChemPass_AI

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 month ago

Evogene Strengthens Scientific Leadership by Appointing Two Professors to Advisory Board Evogene Ltd. enhances its scientific team by announcing the appointment of two renowned professors. This move aims to support its innovative ChemPass AI™.

Evogene Strengthens Scientific Leadership by Appointing Two Professors to Advisory Board #Israel #Rehovot #Evogene #ChemPass_AI #John_Irwin

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 month ago

Evogene Partners with Shanghai Lishan Biopharmaceuticals for Groundbreaking Cancer Therapy Evogene and Shanghai Lishan Biopharmaceuticals have entered into an exclusive collaboration to advance BMC128, a microbiome-based cancer treatment showing promising early results in clinical studies.

Evogene Partners with Shanghai Lishan Biopharmaceuticals for Groundbreaking Cancer Therapy #Israel #Rehovot #Evogene #Lishan_Biotech #BMC128

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 months ago

Evogene and Unravel Biosciences Collaborate on Groundbreaking Neurological Therapy Evogene and Unravel Biosciences have partnered to create a revolutionary therapy aimed at reversing neurological damage in demyelinating disorders, driven by advanced technologies.

Evogene and Unravel Biosciences Collaborate on Groundbreaking Neurological Therapy #Israel #Rehovot #Evogene #Neurological_Therapy #Unravel_Biosc

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 months ago

Evogene Names Dr. Olga Nissan as New VP of Business Development to Drive Growth Dr. Olga Nissan has been appointed VP of Business Development at Evogene, bringing extensive expertise in biotech and pharma to accelerate innovation.

Evogene Names Dr. Olga Nissan as New VP of Business Development to Drive Growth #Israel #Rehovot #Evogene #ChemPass_AI #Dr._Nissan

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

6 months ago

Evogene to Showcase Innovative ChemPass AI Strategy at H.C. Wainwright Global Conference Evogene's CEO Ofer Haviv will present the company's ChemPass AI strategy at the H.C. Wainwright 27th Annual Global Investment Conference in New York, focusing on advancements in small molecule discovery.

Evogene to Showcase Innovative ChemPass AI Strategy at H.C. Wainwright Global Conference #United_States #New_York #Evogene #ChemPass_AI #Ofer_Haviv

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

6 months ago

Evogene's Q2 2025 Financial Results Highlight Strategic Shift and Future Opportunities Evogene has shared its second quarter 2025 financial results, revealing significant strategic changes and future prospects in pharmaceuticals and agriculture.

Evogene's Q2 2025 Financial Results Highlight Strategic Shift and Future Opportunities #Israel #Rehovot #Evogene #Lavie_Bio #ChemPass_AI

1 0 0 0

Thiard News@F4F

@newsen.bsky.social

7 months ago

Evogene Teams Up with Tel Aviv University to Target Metabolic Diseases with Innovative Therapies Evogene Ltd. collaborates with Professor Ehud Gazit at Tel Aviv University to create new drugs aimed at metabolic disorders caused by toxic metabolite aggregation, paving the way for innovative treatments.

Evogene Teams Up with Tel Aviv University to Target Metabolic Diseases with Innovative Therapies #Israel #Rehovot #Evogene #Tel_Aviv_University #Ehud_Gazit

0 0 0 0

@agritradenews.bsky.social

7 months ago

Cefetra advert

The ICL Group has completed its acquisition of the majority of Israeli computational biology specialist Evogene’s agricultural biologicals subsidiary Lavie Bio. #Evogene #ICLGroup #LavieBio
bit.ly/3IuwykJ

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

8 months ago

Evogene Completes Successful Sale of Lavie Bio to ICL Group, Expanding Agricultural Technologies Evogene has finalized its transaction selling Lavie Bio Ltd. to ICL Group, enhancing support for sustainable agriculture innovation through advanced technologies.

Evogene Completes Successful Sale of Lavie Bio to ICL Group, Expanding Agricultural Technologies #Israel #Rehovot #Evogene #ICL_Group #Lavie_Bio

0 0 0 0

@agritradenews.bsky.social

10 months ago

The Israeli multinational chemicals group ICL, which owns the polyhalite fertiliser mine at Boulby in Cleveland, has acquired the majority of the Lavie Bio business from Evogene, also based in Israel. #Evogene #ICLGroup #LavieBio
bit.ly/4daLAao

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago